Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide. Reactive oxygen species (ROS), as potent oxidants in cells, have been shown to promote the development of NAFLD. Previous studies reported that for ROS-induced cellular oxidative stress, promoting lipid dro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cells (Basel, Switzerland) Switzerland), 2019-10, Vol.8 (10), p.1241
Hauptverfasser: Tan, Yanjie, Jin, Yi, Wang, Qian, Huang, Jin, Wu, Xiang, Ren, Zhuqing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide. Reactive oxygen species (ROS), as potent oxidants in cells, have been shown to promote the development of NAFLD. Previous studies reported that for ROS-induced cellular oxidative stress, promoting lipid droplet (LD) accumulation is associated with the cellular antioxidation process. However, the regulatory role of LDs in relieving cellular oxidative stress is poorly understood. Here, we showed that ( ), a key LD protein related to mitochondria-LD contact, reduced ROS levels and improved mitochondrial function in HepG2 cells. Both mRNA and protein levels of were significantly increased in cells with hydrogen peroxide or lipopolysaccharide (LPS) treatment ( < 0.05). Additionally, the overexpression of promoted LD formation and mitochondria-LD contact, reduced cellular ROS levels and up-regulated mitochondrial function-related genes such as and . Knockdown , meanwhile, showed opposite effects. Furthermore, we identified that cellular oxidative stress up-regulated expression via the JNK-p38-ATF pathway. This study shows that the up-regulation of is a kind of survival strategy for cells in response to stress. can be a potential therapeutic target in NAFLD.
ISSN:2073-4409
2073-4409
DOI:10.3390/cells8101241